Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AliCsa trial of oral alitretinoin versus oral cyclosporine for moderate to very severe hand eczema
NL-OMON60095Phase 4Not yet recruiting
- Sponsor
- University Medical Center Groningen
- Start
- May 2016
- Modality
- Small Molecules, Peptides, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial in hand dermatitis comparing Alitretinoin arm with Cyclosporine arm (2 arms). Primary endpoint: Primary efficacy endpoint. Planned start May 2016; status: not yet recruiting.
02
Drugs
alitretinoincyclosporine
03
Conditions
hand dermatitis
Beyond the preview
Go deeper on NL-OMON60095.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60095.